Despite hundreds of published models for cancer drug response prediction, none are used in clinical practice.
Why?
In our preprint, we outline key challenges and introduce a living benchmark to help the field move forward.
Check out the thread by my co–first author
@judith-bernett.bsky.social:
add a skeleton here at some point
4 months ago
